Role of adiponectin in matching of fetal and placental weight in mothers with type 1 diabetes

Diabetes Care. 2008 Jun;31(6):1123-5. doi: 10.2337/dc07-2195. Epub 2008 Mar 13.

Abstract

Objective: To assess the association of fetal hormones with placental growth and fetal weight-to-placental weight ratio index (FPI) in pregnancies complicated by maternal diabetes.

Research design and methods: We conducted a prospective study using umbilical venous blood samples taken at birth from 122 offspring of mothers with type 1 diabetes (OT1D) and 46 control subjects.

Results: Placental weight (P = 0.009) and gestation-adjusted birth weight (P < 0.001) were increased in OT1D, but FPI was unaltered (P = 0.33). Placental weight correlated with birth weight (P < 0.001) and cord leptin (P < 0.001) in control subjects and OT1D, with further relationships with cord insulin, IGF-1, IGF-binding protein-3 (IGFBP-3), and triceps and subscapular thickness in OT1D. FPI was associated with adiponectin in both groups, even after adjustment for confounders.

Conclusions: Placental and fetal growth show a parallel increase in mothers with type 1 diabetes. The possible role of adiponectin in matching of fetal and placental growth merits further study.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adiponectin / blood*
  • Birth Weight*
  • Diabetes Mellitus, Type 1 / complications*
  • Diabetes Mellitus, Type 1 / physiopathology
  • Female
  • Fetal Blood / chemistry
  • Fetal Development
  • Fetal Weight / physiology*
  • Humans
  • Infant, Newborn
  • Insulin / blood
  • Insulin-Like Growth Factor I / metabolism
  • Leptin / blood
  • Organ Size
  • Placenta / anatomy & histology*
  • Pregnancy
  • Pregnancy Complications / physiopathology

Substances

  • Adiponectin
  • Insulin
  • Leptin
  • Insulin-Like Growth Factor I